The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today it offers policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.
The EMCDDA was set up to provide 'factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences'
The EMCDDA and the University Institute of Lisbon (ISCTE-IUL) are offering two upcoming events in 2021: the European Drugs Winter School (EDWS) and the European Drugs Summer School (EDSS).
The EDWS will take place as a virtual event from 1–12 March 2021 and will explore the theme of 'Responses to, and preparedness for, health-related threats (COVID-19 lessons learned)'.
The EMCDDA is offering a series of webinars around the theme of COVID-19. The purpose of the webinars is to help those working in the drugs field understand how drug users, and those supporting them, are coping with the pandemic and to share knowledge and experience. The webinars will give a voice to key professionals working in the drugs field and will allow for a panel discussion on emerging challenges.
The most recent report of the European School Survey Project on Alcohol and Other Drugs (ESPAD) will be published on 12 November 2020. The ESPAD Report 2019 is based on a 2019 survey in 35 Europen countries. ESPAD has been collecting data through school surveys every four years since 1995. Further iinformation is available on the ESPAD website.
